Skip to main content
. 2009 Oct 1;30(2):103–111. doi: 10.1038/jp.2009.142

Table 5. Predictors of subnormal weight (<–2 s.d.) at 20 months corrected age, results of stepwise logistic regression analysis.

Variable Stage I Stage II Stage II Stage IV
  OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Time period (I vs II) 0.39 (0.21,0.72)** 0.34 (0.17,0.71)** 0.26 (0.12,0.56)** 0.26 (0.12,0.58)**
                 
Sociodemographic status
 Maternal education <high school 0.86 (0.38,1.96) 0.81 (0.35,1.88) 0.96 (0.41,2.26) 0.97 (0.40,2.31)
 Race 0.87 (0.48,1.60) 0.83 (0.45,1.55) 0.75 (0.39,1.42) 0.71 (0.37,1.37)
 Sex of child 1.39 (0.77,2.50) 1.41 (0.77,2.57) 1.44 (0.78,2.69) 1.43 (0.76,2.71)
 Multiple birth 1.21 (0.56,2.62) 1.17 (0.52,2.63) 1.42 (0.61,3.30) 1.32 (0.56,3.12)
                 
Neonatal therapy
 Surfactant     1.97 (0.59,6.64) 2.02 (0.58,7.12) 2.40 (0.65,8.83)
 Postnatal steroids     1.17 (0.59,2.33) 0.77 (0.36,1.65) 0.65 (0.30,1.43)
 Indomethacin     1.95 (0.95,3.98) 1.94 (0.93,4.05) 1.85 (0.88,3.90)
 PDA ligation     0.78 (0.40,1.53) 0.66 (0.32,1.33) 0.60 (0.29,1.24)
                 
Neonatal morbidity
 Severity of lung diseasea         1.02 (1.00,1.03)* 1.01 (1.00,1.03)*
 Severely abnormal ultrasoundb         2.49 (1.17,5.30)* 1.56 (0.68,3.61)
                 
Neurosensory outcome             3.03 (1.39,6.62)**

Abbreviations: 95% C.I., 95% confidence interval; OR, odds ratio; PDA, patent ductus arteriosus.

a

Days on ventilator.

b

Includes grades III–IV hemorrhage, periventricular leukomalacia and ventricular dilatation at discharge.

*P<0.05, **P<0.001.